{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T09:02:04Z","timestamp":1789549324790,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"DOI":"10.1007\/s00408-026-00936-5","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T08:02:28Z","timestamp":1789545748000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dupilumab Alleviates Pulmonary Fibrosis by Interrupting Profibrotic Macrophage-Fibroblast Crosstalk and IL4R\/JAK\/STAT Signaling"],"prefix":"10.1007","volume":"204","author":[{"given":"Qi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yupei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruxuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoyan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honggang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7184-0005","authenticated-orcid":false,"given":"Hui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"936_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114653","volume":"155","author":"F Gao","year":"2025","unstructured":"Gao F, Pan L, Liu W et al (2025) Idiopathic pulmonary fibrosis microenvironment: novel mechanisms and research directions. Int Immunopharmacol 155:114653. https:\/\/doi.org\/10.1016\/j.intimp.2025.114653","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"936_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-025-03836-1","volume":"25","author":"N Golchin","year":"2025","unstructured":"Golchin N, Patel A, Scheuring J et al (2025) Incidence and prevalence of idiopathic pulmonary fibrosis: a systematic literature review and meta-analysis. BMC Pulm Med 25(1):378. https:\/\/doi.org\/10.1186\/s12890-025-03836-1","journal-title":"BMC Pulm Med"},{"issue":"1","key":"936_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines14010090","volume":"14","author":"L Senhaji","year":"2026","unstructured":"Senhaji L, Senhaji N, Abbassi M et al (2026) Idiopathic pulmonary fibrosis: a comprehensive review of risk factors, genetics, diagnosis, and therapeutic approaches. Biomedicines 14(1):90. https:\/\/doi.org\/10.3390\/biomedicines14010090","journal-title":"Biomedicines"},{"issue":"11","key":"936_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26115393","volume":"26","author":"N Jones","year":"2025","unstructured":"Jones N, Rahar B, Bernau K et al (2025) Mechanisms on how matricellular microenvironments sustain idiopathic pulmonary fibrosis. Int J Mol Sci 26(11):5393. https:\/\/doi.org\/10.3390\/ijms26115393","journal-title":"Int J Mol Sci"},{"issue":"3","key":"936_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.70094","volume":"86","author":"D Kahvecioglu","year":"2025","unstructured":"Kahvecioglu D (2025) Molecular pathways in idiopathic pulmonary fibrosis: a review of novel insights for drug design. Drug Dev Res 86(3):e70094. https:\/\/doi.org\/10.1002\/ddr.70094","journal-title":"Drug Dev Res"},{"issue":"22","key":"936_CR6","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1056\/NEJMoa2414108","volume":"392","author":"L Richeldi","year":"2025","unstructured":"Richeldi L, Azuma A, Cottin V et al (2025) Nerandomilast in patients with idiopathic pulmonary fibrosis. N Engl J Med 392(22):2193\u20132202. https:\/\/doi.org\/10.1056\/NEJMoa2414108","journal-title":"N Engl J Med"},{"issue":"8","key":"936_CR7","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1084\/jem.20162152","volume":"214","author":"AV Misharin","year":"2017","unstructured":"Misharin AV, Morales-Nebreda L, Reyfman PA et al (2017) Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span. J Exp Med 214(8):2387\u20132404. https:\/\/doi.org\/10.1084\/jem.20162152","journal-title":"J Exp Med"},{"issue":"12","key":"936_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70521","volume":"6","author":"L Zuo","year":"2020","unstructured":"Zuo L, Liu Q, Ye D et al (2020) Idiopathic pulmonary fibrosis: cellular heterogeneity, mechanisms, and therapeutic implications. MedComm 6(12):e70521. https:\/\/doi.org\/10.1002\/mco2.70521","journal-title":"MedComm"},{"issue":"12","key":"936_CR9","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1164\/rccm.201712-2410OC","volume":"199","author":"PA Reyfman","year":"2019","unstructured":"Reyfman PA, Walter JM, Joshi N et al (2019) Single-cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis. Am J Respir Crit Care Med 199(12):1517\u20131536. https:\/\/doi.org\/10.1164\/rccm.201712-2410OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"936_CR10","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1164\/rccm.202306-0979OC","volume":"210","author":"A Unterman","year":"2024","unstructured":"Unterman A, Zhao AY, Neumark N et al (2024) Single-cell profiling reveals immune aberrations in progressive idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 210(4):484\u2013496. https:\/\/doi.org\/10.1164\/rccm.202306-0979OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"936_CR11","doi-asserted-by":"publisher","first-page":"1802441","DOI":"10.1183\/13993003.02441-2018","volume":"54","author":"C Morse","year":"2019","unstructured":"Morse C, Tabib T, Sembrat J et al (2019) Proliferating SPP1\/MERTK-expressing macrophages in idiopathic pulmonary fibrosis. Eur Respir J 54(2):1802441. https:\/\/doi.org\/10.1183\/13993003.02441-2018","journal-title":"Eur Respir J"},{"issue":"4","key":"936_CR12","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202302584RR","volume":"38","author":"EJ Goetzl","year":"2024","unstructured":"Goetzl EJ (2024) Th2 cells in rapid immune responses and protective avoidance reactions. FASEB J 38(4):e23485. https:\/\/doi.org\/10.1096\/fj.202302584RR","journal-title":"FASEB J"},{"issue":"6","key":"936_CR13","doi-asserted-by":"publisher","first-page":"1801130","DOI":"10.1183\/13993003.01130-2018","volume":"52","author":"G Raghu","year":"2018","unstructured":"Raghu G, Richeldi L, Crestani B et al (2018) SAR156597 in idiopathic pulmonary fibrosis: a phase 2 placebo-controlled study (DRI11772). Eur Respir J 52(6):1801130. https:\/\/doi.org\/10.1183\/13993003.01130-2018","journal-title":"Eur Respir J"},{"issue":"4","key":"936_CR14","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1165\/rcmb.2022-0301OC","volume":"69","author":"H Mattoo","year":"2023","unstructured":"Mattoo H, Bangari DS, Cummings S et al (2023) Molecular features and stages of pulmonary fibrosis driven by type 2 inflammation. Am J Respir Cell Mol Biol 69(4):404\u2013421. https:\/\/doi.org\/10.1165\/rcmb.2022-0301OC","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"936_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/cea.13491","volume":"50","author":"H Harb","year":"2020","unstructured":"Harb H, Chatila TA (2020) Mechanisms of Dupilumab. Clin Exp Allergy 50(1):5\u201314. https:\/\/doi.org\/10.1111\/cea.13491","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"936_CR16","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2217\/imt-2020-0270","volume":"13","author":"R Talotta","year":"2021","unstructured":"Talotta R (2021) The rationale for targeting the JAK\/STAT pathway in scleroderma-associated interstitial lung disease. Immunotherapy 13(3):241\u2013256. https:\/\/doi.org\/10.2217\/imt-2020-0270","journal-title":"Immunotherapy"},{"issue":"Pt A","key":"936_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109424","volume":"113","author":"B Liu","year":"2022","unstructured":"Liu B, Jiang Q, Chen R et al (2022) Tacrolimus ameliorates bleomycin-induced pulmonary fibrosis by inhibiting M2 macrophage polarization via JAK2\/STAT3 signaling. Int Immunopharmacol 113(Pt A):109424. https:\/\/doi.org\/10.1016\/j.intimp.2022.109424","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"936_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/biom13040634","volume":"13","author":"H Olbrich","year":"2023","unstructured":"Olbrich H, Sadik CD, Ludwig RJ et al (2023) Dupilumab in inflammatory skin diseases: a systematic review. Biomolecules 13(4):634. https:\/\/doi.org\/10.3390\/biom13040634","journal-title":"Biomolecules"},{"issue":"8","key":"936_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13899","volume":"17","author":"MR McCann","year":"2024","unstructured":"McCann MR, Kosloski MP, Xu C et al (2024) Dupilumab: mechanism of action, clinical, and translational science. Clin Transl Sci 17(8):e13899. https:\/\/doi.org\/10.1111\/cts.13899","journal-title":"Clin Transl Sci"},{"key":"936_CR20","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3389\/fmed.2017.00118","volume":"4","author":"J Tashiro","year":"2017","unstructured":"Tashiro J, Rubio GA, Limper AH et al (2017) Exploring animal models that resemble idiopathic pulmonary fibrosis. Front Med (Lausanne). 4:118. https:\/\/doi.org\/10.3389\/fmed.2017.00118","journal-title":"Front Med (Lausanne)."},{"key":"936_CR21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.diff.2022.10.001","volume":"128","author":"ZN Mohd Yasin","year":"2022","unstructured":"Mohd Yasin ZN, Mohd Idrus FN, Hoe CH et al (2022) Macrophage polarization in THP-1 cell line and primary monocytes: a systematic review. Differentiation 128:67\u201382. https:\/\/doi.org\/10.1016\/j.diff.2022.10.001","journal-title":"Differentiation"},{"issue":"9","key":"936_CR22","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s41584-025-01279-w","volume":"21","author":"M Cutolo","year":"2025","unstructured":"Cutolo M, Soldano S, Smith V et al (2025) Dynamic macrophage phenotypes in autoimmune and inflammatory rheumatic diseases. Nat Rev Rheumatol 21(9):546\u2013565. https:\/\/doi.org\/10.1038\/s41584-025-01279-w","journal-title":"Nat Rev Rheumatol"},{"key":"936_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173090","volume":"877","author":"C Yunna","year":"2020","unstructured":"Yunna C, Mengru H, Lei W et al (2020) Macrophage M1\/M2 polarization. Eur J Pharmacol 877:173090. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173090","journal-title":"Eur J Pharmacol"},{"key":"936_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1444964","volume":"15","author":"Z Ge","year":"2024","unstructured":"Ge Z, Chen Y, Ma L et al (2024) Macrophage polarization and its impact on idiopathic pulmonary fibrosis. Front Immunol 15:1444964. https:\/\/doi.org\/10.3389\/fimmu.2024.1444964","journal-title":"Front Immunol"},{"key":"936_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9523","volume":"6","author":"S Su","year":"2015","unstructured":"Su S, Zhao Q, He C et al (2015) MiR-142-5p and miR-130a-3p are regulated by IL-4 and IL-13 and control profibrogenic macrophage program. Nat Commun 6:8523. https:\/\/doi.org\/10.1038\/ncomms9523","journal-title":"Nat Commun"},{"issue":"4","key":"936_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11040693","volume":"11","author":"M Bruzova","year":"2021","unstructured":"Bruzova M, Pavlova M, Matej R et al (2021) Interstitial score and concentrations of IL-4R\u03b1, PAR-2, and MMP-7 in bronchoalveolar lavage fluid could be useful markers for distinguishing idiopathic interstitial pneumonias. Diagnostics (Basel) 11(4):693. https:\/\/doi.org\/10.3390\/diagnostics11040693","journal-title":"Diagnostics (Basel)"},{"issue":"5","key":"936_CR27","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1111\/all.14151","volume":"75","author":"A Le Floc\u2019h","year":"2020","unstructured":"Le Floc\u2019h A, Allinne J, Nagashima K et al (2020) Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4R\u03b1 antibody, is required to broadly inhibit type 2 inflammation. Allergy 75(5):1188\u20131204. https:\/\/doi.org\/10.1111\/all.14151","journal-title":"Allergy"},{"issue":"6","key":"936_CR28","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02111-2018","volume":"52","author":"MS Wijsenbeek","year":"2018","unstructured":"Wijsenbeek MS, Kool M, Cottin V (2018) Targeting interleukin-13 in idiopathic pulmonary fibrosis: from promising path to dead end. Eur Respir J 52(6):1802111. https:\/\/doi.org\/10.1183\/13993003.02111-2018","journal-title":"Eur Respir J"},{"issue":"1","key":"936_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-018-0728-9","volume":"19","author":"J Milara","year":"2018","unstructured":"Milara J, Hernandez G, Ballester B et al (2018) The JAK2 pathway is activated in idiopathic pulmonary fibrosis. Respir Res 19(1):24. https:\/\/doi.org\/10.1186\/s12931-018-0728-9","journal-title":"Respir Res"},{"issue":"12","key":"936_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22126211","volume":"22","author":"P Montero","year":"2021","unstructured":"Montero P, Milara J, Roger I et al (2021) Role of JAK\/STAT in interstitial lung diseases; molecular and cellular mechanisms. Int J Mol Sci 22(12):6211. https:\/\/doi.org\/10.3390\/ijms22126211","journal-title":"Int J Mol Sci"},{"issue":"1","key":"936_CR31","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s42358-023-00305-3","volume":"63","author":"D Wang","year":"2023","unstructured":"Wang D, Wei Y, Xu L et al (2023) Crosstalk between the JAK2 and TGF-\u03b21 signaling pathways in scleroderma-related interstitial lung disease targeted by baricitinib. Adv Rheumatol 63(1):22. https:\/\/doi.org\/10.1186\/s42358-023-00305-3","journal-title":"Adv Rheumatol"},{"issue":"4","key":"936_CR32","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2024.5413","volume":"54","author":"X Yang","year":"2024","unstructured":"Yang X, Liu Z, Zhou J et al (2024) SPP1 promotes the polarization of M2 macrophages through the Jak2\/Stat3 signaling pathway and accelerates the progression of idiopathic pulmonary fibrosis. Int J Mol Med 54(4):89. https:\/\/doi.org\/10.3892\/ijmm.2024.5413","journal-title":"Int J Mol Med"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-026-00936-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00408-026-00936-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-026-00936-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T08:02:29Z","timestamp":1789545749000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00408-026-00936-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["936"],"URL":"https:\/\/doi.org\/10.1007\/s00408-026-00936-5","relation":{},"ISSN":["1432-1750"],"issn-type":[{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"assertion":[{"value":"30 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors report no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were conducted following established ethical guidelines and institutional animal care regulations for animal research and received formal approval from the Institutional Animal Care and Use Committee (IACUC) of NanKai Animal Resources Center (Approval No. 2024-SYDWLL-000001).","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"69"}}